Procurement Summary
Country : USA
Summary : Notice of Intent to Sole Source - Pharmaceuticals Duodote
Deadline : 18 Sep 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 88926172
Document Ref. No. :
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Office of Resource Management (ORM), Strategic National Stockpile (SNS) intend to use other than full and open competition to award a sole source contract to Meridian Medical Technologies, LLC to provide DuoDote Single Dose Autoinjector due to unexpected FDA testing failures of Antidote Nerve Agent Autoinjector (ATNAA) which has caused and inventory shortage and denial to State and local agencies that depend on SNS medical countermeasures used for medical and national emergencies.
This notice of intent to award a sole source contract will be posted for five (5) calendar days to verify that no other sources can meet this requirement given only one responsible source and no other supplies or services will satisfy the Government requirements. This five (5) calendar day notice shall expire on September 18, 2023 at 12:00 PM Eastern Standard Time.
If no credible responses to the intent to sole source are received, the Government intends negotiate a fixed price contract to Meridian Medical Technologies, LLC. The proposed contract action will
support supplies and services for which the Government intends to solicit and negotiate with only one source under the authority of the Federal Acquisition Regulation (FAR) 6.302-1 entitled Only one responsible source and no other supplies or services will satisfy agency requirements, 41 U.S.C. 3304(a)(3). This notice of intent is NOT a request for competitive proposals.
Interested parties may identify their interest and capability to respond to this requirement by submitting in writing their name, address, telephone number, email, and a statement regarding capability to provide the specified requirement.
Responses shall be limited to ten (10) pages or less, including all attachments. Interested parties will be considered only if they respond to this notice with clear and c...
Active Contract Opportunity
Notice ID :
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office : ASPR/ORM-SNS
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Sep 14, 2023 05:14 pm EDT
Original Response Date: Sep 18, 2023 12:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 03, 2023
Initiative: None
Classification
Original Set Aside:
Product Service Code: 3650 - CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: Atlanta, GA 30341 USA
Documents
Tender Notice